Literature DB >> 25139246

Retrograde closure of perimembranous ventricular septal defect using muscular ventricular septal occluder: a single-center experience of a novel technique.

Kalyanasundaram Muthusamy1.   

Abstract

We herein report the advantages of retrograde ventricular septal defect (VSD) closure using a muscular VSD device for perimembranous VSDs. Perimembranous VSDs are conventionally closed by an antegrade technique (arteriovenous looping technique) using a patent ductus arteriosus or asymmetric perimembranous VSD device. However, we used a symmetrical muscular VSD device in all cases described in this report. Use of the antegrade technique for the first few patients with VSD resulted in prolonged procedural and fluoroscopic times and frequent slippage of the device into the right ventricle. Subsequent use of the retrograde technique shortened the procedural time and allowed for easier closure of the perimembranous VSD. We performed retrograde closure of perimembranous VSDs using a symmetrical muscular VSD device in 130 patients. We obtained a high rate of successful deployment (88.5%) and a low rate of complications (6.0%). We also achieved shorter procedural and fluoroscopic times than those associated with the antegrade technique.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25139246     DOI: 10.1007/s00246-014-0971-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial.

Authors:  Yun-Ching Fu; John Bass; Zahid Amin; Wolfgang Radtke; John P Cheatham; William E Hellenbrand; David Balzer; Qi-Ling Cao; Ziyad M Hijazi
Journal:  J Am Coll Cardiol       Date:  2006-01-17       Impact factor: 24.094

2.  Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study.

Authors:  J Masura; W Gao; P Gavora; K Sun; A Q Zhou; S Jiang; L Ting-Liang; Y Wang
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

3.  Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry.

Authors:  Ralf Holzer; Jo de Giovanni; Kevin P Walsh; Andrew Tometzki; Th Goh; Fakhri Hakim; Carlos Zabal; Jose Suarez de Lezo; Qi-Ling Cao; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2006-10       Impact factor: 2.692

4.  Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.

Authors:  Robin J Pinto; Bharat V Dalvi; Satyavan Sharma
Journal:  Catheter Cardiovasc Interv       Date:  2006-07       Impact factor: 2.692

5.  Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect.

Authors:  William C L Yip; Frank Zimmerman; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2005-11       Impact factor: 2.692

6.  Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience.

Authors:  Ziyad M Hijazi; Fakhri Hakim; A Abu Haweleh; Awni Madani; Walid Tarawna; Aktham Hiari; Qi-Ling Cao
Journal:  Catheter Cardiovasc Interv       Date:  2002-08       Impact factor: 2.692

7.  Initial human experience with the Amplatzer perimembranous ventricular septal occluder device.

Authors:  John L Bass; G S Kalra; Ramesh Arora; Jozef Masura; Pavlo Gavora; Basil D Thanopoulos; William Torres; Horst Sievert; Mario Carminati; Gunther Fischer; Peter Ewert
Journal:  Catheter Cardiovasc Interv       Date:  2003-02       Impact factor: 2.692

8.  Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder.

Authors:  Basil Vasilios D Thanopoulos; Michael L Rigby; Evangelos Karanasios; Christodoulos Stefanadis; Nico Blom; Jaap Ottenkamp; Armine Zarayelyan
Journal:  Am J Cardiol       Date:  2007-02-16       Impact factor: 2.778

9.  Primary transcatheter umbrella closure of perimembranous ventricular septal defect.

Authors:  M L Rigby; A N Redington
Journal:  Br Heart J       Date:  1994-10

10.  Invasive measurements of atrioventricular conduction parameters prior to and following ventricular septal defect closure with the amplatzer device.

Authors:  Euloge Kouadio Kramoh; Nagib Dahdah; Anne Fournier; Shubhayan Sanatani; Martin Hosking; Joaquim Miró
Journal:  J Invasive Cardiol       Date:  2008-05       Impact factor: 2.022

View more
  3 in total

1.  Percutaneous closure of ventricular septal defects in children: key parameters affecting patient radiation exposure.

Authors:  Raymond N Haddad; Chadia Rizk; Zakhia Saliba; Jad Farah
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

2.  Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach.

Authors:  Nihat Pekel; Ertuğrul Ercan; Mehmet Emre Özpelit; Ferhat Özyurtlu; Akar Yılmaz; Caner Topaloğlu; Serkan Saygı; Serkan Yakan; İstemihan Tengiz
Journal:  Anatol J Cardiol       Date:  2017-02-21       Impact factor: 1.596

3.  Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach.

Authors:  Sedigheh Saedi; Tahereh Saedi
Journal:  Anatol J Cardiol       Date:  2017-05-09       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.